Essential role for p53 and caspase-9 in DNA damaging drug-induced apoptosis in neuroblastoma IMR32 Cells

DNA and Cell Biology

Volumn 30, Issue 12, 2011, Pages 1045-1050

  Li, Tai ^a   Cui, Zhao Bo ^b   Ke, Xiao Xue ^a   Tan, Juan ^a   Li, Fang Fang ^a   Li, Ting ^a   Wang, Xiang Wei ^c   Cui, Hong Juan ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL POPULATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA FRAGMENTATION; DRUG RESISTANCE; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE TRANSFER; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CASPASE 9; CELL LINE, TUMOR; DNA DAMAGE; DNA, NEOPLASM; DOXORUBICIN; GENES, P53; HUMANS; NEOPLASM PROTEINS; NEUROBLASTOMA; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 82955161699     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1255     Document Type: Article

References (49)

1. Adams, J.M., and Cory, S. (2007). The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26, 1324-1337. (Pubitemid 46328466)
2. Barak, Y., Juven, T., Haffner, R., and Oren, M. (1993). mdm2 expression is induced by wild-type p53 activity. EMBO J 12, 461-468. (Pubitemid 23073692)
3. Brodeur, G.M. (2003). Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3, 203-216. (Pubitemid 37328872)
4. Brown, J.P., and Pagano, M. (1997). Mechanism of p53 degradation. Biochim Biophys Acta 1332, O1-O6. (Pubitemid 27211622)
5. Canete, A., Gerrard, M., Rubie, H., Castel, V., Di Cataldo, A., Munzer, C., et al. (2009). Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience. J Clin Oncol 27, 1014-1019.
6. Castresana, J.S., Bello, M.J., Rey, J.A., Nebreda, P., Queizan, A., Garcia-Miguel, P., et al. (1994). No TP53 mutations in neuro-blastomas detected by PCR-SSCP analysis. Genes Chrom Cancer 10, 136-138. (Pubitemid 24155984)
7. Choi, M.S., Yuk, D.Y., Oh, J.H., Jung, H.Y., Han, S.B., Moon, D.C., et al. (2008). Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis. An-ticancer Res 28, 3777-3784.
8. Craxton, A., Draves, K.E., Gruppi, A., and Clark, E.A. (2005). BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 202, 1363-1374. (Pubitemid 41668739)
9. Cui, H., Hu, B., Li, T., Ma, J., Alam, G., Gunning, W.T., et al. (2007). Bmi-1 is essential for the tumorigenicity of neuroblas-toma cells. Am J Pathol 170, 1370-1378. (Pubitemid 47339343)
10. Cui, H., Li, T., and Ding, H.F. (2005). Linking of N-Myc to death receptor machinery in neuroblastoma cells. J Biol Chem 280, 9474-9481. (Pubitemid 40409642)
11. Cui, H., Schroering, A., and Ding, H.F. (2002). p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol Cancer Ther 1, 679-686.
12. Day, T.W., Wu, C.H., and Safa, A.R. (2009). Etoposide induces protein kinase Cdelta-and caspase-3-dependent ap-optosis in neuroblastoma cancer cells. Mol Pharmacol 76, 632-640.
13. Eggert, A., Ikegaki, N., Liu, X.G., and Brodeur, G.M. (2000). Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma. Klin Padiatr 212, 200-205. (Pubitemid 30650555)
14. El-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trent, J.M., et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825. (Pubitemid 23346378)
15. Goldman, S.C., Chen, C.Y., Lansing, T.J., Gilmer, T.M., and Kastan, M.B. (1996). The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Am J Pathol 148, 1381-1385. (Pubitemid 26135882)
16. Hakem, R., Hakem, A., Duncan, G.S., Henderson, J.T., Woo, M., Soengas, M.S., et al. (1998). Differential requirement for cas-pase 9 in apoptotic pathways in vivo. Cell 94, 339-352. (Pubitemid 28376078)
17. Hemann, M.T., Bric, A., Teruya-Feldstein, J., Herbst, A., Nilsson, J.A., Cordon-Cardo, C., et al. (2005). Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 436, 807-811. (Pubitemid 41160633)
18. Herrmann, M., Lorenz, H.M., Voll, R., Grunke, M., Woith, W., and Kalden, J.R. (1994). A rapid and simple method for the isolation of apoptotic DNA fragments. Nucleic Acids Res 22, 5506-5507.
19. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. (1991). p53 mutations in human cancers. Science 253, 49-53. (Pubitemid 21917115)
20. Hosoi, G., Hara, J., Okamura, T., Osugi, Y., Ishihara, S., Fuku-zawa, M., et al. (1994). Low frequency of the p53 gene mutations in neuroblastoma. Cancer 73, 3087-3093. (Pubitemid 24170786)
21. Imamura, J., Bartram, C., Berthold, F., Harms, D., Nakamura, H., and Koeffler, H. (1993). Mutation of the p53 gene in neuro-blastoma and its relationship with N-myc amplification. Cancer Res 53, 4053-4058. (Pubitemid 23267710)
22. Jacobs, J.F., van Bokhoven, H., van Leeuwen, F.N., Hulsbergen-van de Kaa, C.A., de Vries, I.J., Adema, G.J., et al. (2009). Regulation of MYCN expression in human neuroblastoma cells. BMC Cancer 9, 239.
23. Keshelava, N., Zuo, J.J., Chen, P., Waidyaratne, S.N., Luna, M.C., Gomer, C.J., et al. (2001). Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines. Cancer Res 61, 6185-6193. (Pubitemid 32768583)
24. Komuro, H., Hayashi, Y., Kawamura, M., Hayashi, K., Kaneko, Y., Kamoshita, S., et al. (1993). Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 53, 5284-5288. (Pubitemid 23333400)
25. Kuida, K., Haydar, T.F., Kuan, C.-Y., Gu, Y., Taya, C., Kar-asuyama, H., et al. (1998). Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325-337. (Pubitemid 28376077)
26. Kusafuka, T., Fukuzawa, M., Oue, T., Komoto, Y., Yoneda, A., and Okada, A. (1997). Mutation analysis of p53 gene in childhood malignant solid tumors. J Pediatr Surg 32, 1175-1180. (Pubitemid 27475893)
27. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489. (Pubitemid 27508237)
28. Lindstrom, M.S., Klangby, U., and Wiman, K.G. (2001). p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Oncogene 20, 2171-2177. (Pubitemid 32424011)
29. Liu, X.S., Kim, C.N., Yang, J., Jemmerson, R., and Wang, X.D. (1996). Induction of apoptotic program in cell-free extracts-requirement for dATP and cytochrome c. Cell 86, 147-157. (Pubitemid 26256586)
30. Lowe, S.W., Ruley, H.E., Jacks, T., and Housman, D.E. (1993a). p53-dependent apoptosis modulates the cytotoxicity of anti-cancer agents. Cell 74, 957-967. (Pubitemid 23289454)
31. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. (1993b). p53 is required for radiation-induced apo-ptosis in mouse thymocytes. Nature 362, 847-849. (Pubitemid 23132161)
32. Maris, J.M., Hogarty, M.D., Bagatell, R., and Cohn, S.L. (2007). Neuroblastoma. Lancet 369, 2106-2120. (Pubitemid 46935947)
33. Meletis, K., Wirta, V., Hede, S.M., Nister, M., Lundeberg, J., and Frisen, J. (2006). p53 suppresses the self-renewal of adult neural stem cells. Development 133, 363-369. (Pubitemid 43210724)
34. Ory, D., Neugeboren, B., and Mulligan, R. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 93, 11400-11406. (Pubitemid 26347133)
35. Pizzo, P., and Poplack, D. (1997). Principles and Practice of Pe-diatric Oncolgy, 3rd edition (Lippincott-Raven Publishers, Philadelphia).
36. Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., et al. (2007). Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115. (Pubitemid 46067311)
37. Rich, T., Allen, R., and Wyllie, A. (2000). Defying death after DNA damage. Nature 407, 777-783.
38. Romagnoli, M., Trichet, V., David, C., Clement, M., Moreau, P., Bataille, R., et al. (2007). Significant impact of survivin on myeloma cell growth. Leukemia 21, 1070-1078. (Pubitemid 46672084)
39. Schwab, M., Westermann, F., Hero, B., and Berthold, F. (2003). Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 4, 472-480. (Pubitemid 37009955)
40. Soengas, M.S., Alarcon, R.M., Yoshida, H., Giaccia, A.J., Hakem, R., Mak, T.W., et al. (1999). Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284, 156-159. (Pubitemid 29282071)
41. Srinivasula, S.M., Ahmad, M., Fernandes-Alnemri, T., and Al-nemri, E.S. (1998). Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1, 949-957. (Pubitemid 128379256)
42. Teitz, T., Wei, T., Liu, D., Valentine, V., Valentine, M., Grenet, J., et al. (2002). Caspase-9 and Apaf-1 are expressed and functionally active in humna neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN. Oncogene 21, 1848-1858. (Pubitemid 34259187)
43. Tewey, K., Rowe, T., Yang, L., Halligan, B., and Liu, L. (1984). Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226, 466-468. (Pubitemid 14012819)
44. Tweddle, D., Malcolm, A., Bown, N., Pearson, A., and Lunec, J. (2001). Evidence for the development of p53 mutations after cy-totoxic therapy in a neuroblastoma cell line. Cancer Res 61, 8-13. (Pubitemid 32095689)
45. Vogan, K., Bernstein, M., Leclerc, J.M., Brisson, L., Brossard, J., Brodeur, G.M., et al. (1993). Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53, 5269-5273. (Pubitemid 23333398)
46. Vogelstein, B., Lane, D., and Levine, A. (2000). Surfing the p53 network. Nature 408, 307-310.
47. Wozniak, A., and Ross, W. (1983). DNA damage as a basis for 40-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity. Cancer Res 43, 120-124. (Pubitemid 13172805)
48. Yang, L., Rowe, T., and Liu, L. (1985). Identification of DNA topoisomerase II as an intracellular target of antitumor epi-podophyllotoxins in simian virus 40-infected monkey cells. Cancer Res 45, 5872-5876. (Pubitemid 16218602)
49. Zou, H., Henzel, W.J., Liu, X., Lutschg, A., and Wang, X. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413. (Pubitemid 27347231)